Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.62 |
| ▸ | HTT | P42858 | 4/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12314599 | 0.89 | MAPT (0.50) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL9379101 | 0.77 | MAPT (1.00) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL20569191 | 0.75 | MAPT (0.42) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL1115528 | 0.75 | ALDH1A1 (0.42) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL28991107 | 0.75 | MAPT (0.61) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL30349789 | 0.75 | MAPT (0.61) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL1115747 | 0.74 | MAPT (0.59) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL15005983 | 0.74 | MAPT (0.59) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL30896387 | 0.74 | MAPT (0.59) | MAPTLMNAHTTKDM4ENPSR1 | |
| SCHEMBL15324212 | 0.74 | MAPT (0.59) | MAPTLMNAHTTKDM4ENPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8262949-B2 | Long wavelength shifted benzotriazole uv-absorbers and their use | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| US-8262949-B2 | Long wavelength shifted benzotriazole uv-absorbers and their use | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| EP-2032577-B1 | LONG WAVELENGTH SHIFTED BENZOTRIAZOLE UV-ABSORBERS AND THEIR USE | BASF SE (DE) | 2011-02-02 | — | — | EP | disclosed |
| EP-2032577-B1 | LONG WAVELENGTH SHIFTED BENZOTRIAZOLE UV-ABSORBERS AND THEIR USE | BASF SE (DE) | 2011-02-02 | — | — | EP | disclosed |
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | CIBA CORPORATION | 2010-07-01 | — | — | US | disclosed |
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | CIBA CORPORATION | 2010-07-01 | — | — | US | disclosed |
| WO-2008000646-A1 | LONG WAVELENGTH SHIFTED BENZOTRIAZOLE UV-ABSORBERS AND THEIR USE | CIBA HOLDING INC. (CH) | 2008-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | SULT1A1, GABBR1, TPMT | MAPT 136/4885LMNA 1593/4885HTT 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.